From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Shares of Piramal Pharma (PPL) hit a new peak of Rs 307.85, soaring 13 per cent on the BSE in Wednesday’s intra-day trade ...

Formosa Pharmaceuticals has announced the completion and top-line results from CPN-303, a phase 3 clinical study of APP13007 ...

Pre-earnings options volume in Corvus Pharmaceuticals (CRVS) is normal with calls leading puts 8:5. Implied volatility suggests the market is ...

Shares of Gland Pharma Ltd. were trading with gains of up to 10% on Tuesday, November 5. The stock has corrected 24% over the ...

Stock Market Today: Multibagger stock, Sudarshan Pharma Industries Ltd has declares 1:10 stock split after 400% rally YTD ...

Topline results are anticipated in Q4 2025 and, assuming positive data, Averitas Pharma aims to submit a supplemental new drug application (sNDA) in 2026. [1] Rosenberger DC, Pogatzki-Zahn EM. Chronic ...

According to Meiji Seika Pharma and other sources, Haraguchi described the replicon vaccine, which is designed to replicate ...

Greetings and welcome to Rigel Pharmaceutical's Financial Conference Call for the Third Quarter 2024. At this time, all participants are in a listen-only mode. A brief question and answer session will ...

Pharmaceutical water systems in transformation mode with advanced processes & shift towards analytics: Nandita Vijayasimha, Bengaluru Thursday, November 7, 2024, 08:00 Hrs [IST] I ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

In the dynamic landscape of pharmaceutical and biotechnology regulation, where compliance is crucial yet complex, Mitul Tilala has emerged as a pioneering figure, redefining regulatory excellence.